Roger Longman, Chief Executive Officer

Mr. Longman is recognized as an expert in biopharmaceutical strategy and reimbursement and often speaks at key industry events organized by important trade organizations, investment banks, venture capital firms, and leading biopharma companies.  His most recent focus has been on new value-based approaches to paying for drugs and diagnostics, harnessing tools and systems for objective, transparent analysis of drug value and economic impact.  He is developing these initiatives in collaboration with major provider, payer, pharmaceutical and diagnostic companies, and patient organizations.

Mr. Longman has been involved with the health-care industry for more than 30 years.  At his first venture, Windhover Information, he and his team created a number of industry-standard analytical sources, including must-read strategy publications such as IN VIVO and Start-Up, the strategic transactions database and a major conference business for senior executives.  The business was acquired by Elsevier where for two years Longman ran the company’s pharmaceutical business information group.

Mr. Longman lectures regularly at several leading universities and co-directed the Wharton-Windhover pharmaceutical program at The Wharton School. Mr. Longman completed his BA at Cornell University and MBA at the University of North Carolina at Chapel Hill, then taught for three years at the European division of the University of Maryland.

Our Team

Norman Selby

Executive Chairman

Norman C. Selby has spent 35 years in the healthcare world in a variety of consulting, managerial, investor and Board roles...

read full biography >

Roger Longman

Chief Executive Officer

Mr. Longman is recognized as an expert in biopharmaceutical strategy and reimbursement and often speaks at key...

read full biography >

Susan Raiola

President

Susan Raiola is the President of Real Endpoints. Ms. Raiola has over 10 years of experience in the pharmaceutical consulting...

read full biography >

Jane F. Barlow, MD

EVP & Chief Clinical Officer

Before starting her own firm, Dr. Barlow served as Associate Chief Medical Officer for CVS Health...

read full biography >

Beth Nash, MD

Chief Medical Officer

Dr. Beth Nash is Chief Medical Officer at Real Endpoints, where her team of pharmacists and biostatisticians has developed...

read full biography >

Laura Farmer

SVP, Business Development and Marketing

Laura Farmer leads business development and marketing for Real Endpoints and subsidiary, Reimbursement Intelligence...

read full biography >

Jane Borne, RPh

VP, Pharmacy

Jane Borne, RPh, is responsible for ensuring the clinical credibility and evidence basis of all RE drug evaluation activities...

read full biography >

Heather Ritchie

VP, Product Strategy and Development

Heather Ritchie is VP Product Strategy and Development at Real Endpoints. She works closely with our customers and partners...

read full biography >

Amy Steinkellner, PharmD

Senior Consultant

Amy Steinkellner, PharmD, has worked with the Real Endpoint team since 2012. She serves as senior clinical advisor to the research...

read full biography >

Robert Galvin, MD

Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms...

read full biography >

Michael Sherman, MD

Dr. Michael Sherman serves as Chief Medical Officer and senior vice president for Harvard Pilgrim Health Care...

read full biography >

Dennis Purcell

Dennis is the Founder, Senior Advisor, and previous Senior Managing Partner of Aisling Capital LLC.,  a leading investment firm...

read full biography >

Linda Blackerby

Linda has been serving as the President of Pharma Intelligence at Informa since May 2015, overseeing an income statement...

read full biography >

Arthur Pappas (Observer)

Art has over 30 years of experience as a pharmaceutical industry executive and venture capital investor in...

read full biography >